Gemzar
In the US, Gemzar (gemcitabine systemic) is a member of the drug class antimetabolites and is used to treat Breast Cancer, Breast Cancer - Metastatic, Non-Small Cell Lung Cancer, Ovarian Cancer and Pancreatic Cancer.
US matches:
UK matches:
- GEMZAR 1G (Leaflet)
- GEMZAR 200MG (Leaflet)
Ingredient matches for Gemzar
Gemcitabine is reported as an ingredient of Gemzar in the following countries:
- Bangladesh
- Luxembourg
- Peru
- Singapore
- Slovenia
- Tunisia
Gemcitabine hydrochloride (a derivative of Gemcitabine) is reported as an ingredient of Gemzar in the following countries:
- Australia
- Austria
- Bahrain
- Belgium
- Bosnia & Herzegowina
- Brazil
- Bulgaria
- Canada
- Chile
- China
- Croatia (Hrvatska)
- Czech Republic
- Denmark
- Egypt
- Estonia
- Finland
- France
- Germany
- Greece
- Hong Kong
- Hungary
- Iceland
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Jordan
- Kuwait
- Latvia
- Lebanon
- Lithuania
- Malaysia
- Malta
- Mexico
- Netherlands
- New Zealand
- Norway
- Oman
- Philippines
- Poland
- Portugal
- Qatar
- Russian Federation
- Saudi Arabia
- Serbia
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sweden
- Switzerland
- Syria
- Taiwan
- Thailand
- Turkey
- United Arab Emirates
- United Kingdom
- United States
- Vietnam
- Yemen
International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
